
### [NCIT:C4742](http://purl.obolibrary.org/obo/NCIT_C4742)
**Label:** Benign Squamous Cell Neoplasm

**Subclasses:** [NCIT:C4355](http://purl.obolibrary.org/obo/NCIT_C4355) (Eyelid Squamous Cell Papilloma), [NCIT:C27087](http://purl.obolibrary.org/obo/NCIT_C27087) (Verruca Vulgaris), [NCIT:C6038](http://purl.obolibrary.org/obo/NCIT_C6038) (Oropharyngeal Squamous Papilloma), [NCIT:C3712](http://purl.obolibrary.org/obo/NCIT_C3712) (Squamous Papilloma), [NCIT:C4369](http://purl.obolibrary.org/obo/NCIT_C4369) (Nasal Vestibule Squamous Papilloma), [NCIT:C6376](http://purl.obolibrary.org/obo/NCIT_C6376) (Vestibular Papilloma), [NCIT:C6342](http://purl.obolibrary.org/obo/NCIT_C6342) (Cervical Squamous Papilloma), [NCIT:C4462](http://purl.obolibrary.org/obo/NCIT_C4462) (Squamous Cell Skin Papilloma), [NCIT:C6037](http://purl.obolibrary.org/obo/NCIT_C6037) (Squamous Papilloma of the Nasopharynx), [NCIT:C6224](http://purl.obolibrary.org/obo/NCIT_C6224) (Conjunctival Squamous Papilloma), [NCIT:C7742](http://purl.obolibrary.org/obo/NCIT_C7742) (Squamous Papilloma of the Larynx), [NCIT:C5344](http://purl.obolibrary.org/obo/NCIT_C5344) (Esophageal Squamous Papilloma), [NCIT:C26913](http://purl.obolibrary.org/obo/NCIT_C26913) (Verruca Plantaris), [NCIT:C6374](http://purl.obolibrary.org/obo/NCIT_C6374) (Vaginal Squamous Papilloma), [NCIT:C65165](http://purl.obolibrary.org/obo/NCIT_C65165) (Inverted Squamous Cell Papilloma), [NCIT:C5819](http://purl.obolibrary.org/obo/NCIT_C5819) (Buccal Mucosa Papilloma), [NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis), [NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma), 

**Class expressions from DL-Learner:**

- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.57%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.57%
- Thing 53.00%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 38.93%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 38.93%


